126 A Randomized, Placebo Controlled Trial of Omega-3 Fatty Acids in the Treatment of Young Children with Autism
D. Mankad A. Dupuis S. Smile W. Roberts J. A. Brian T. B. Lui L. Genore D. Zaghloul A. Iaboni M. Marcon E. Anagnostou

127 Atomoxetine Tolerability and Adverse Events in Autism Spectrum Disorders in the Multisite Charts Study
J. A. Hellings S. L. Hyman B. L. Handen T. Smith P. Corbett-Dick R. Tumuluru L. E. Arnold M. G. Aman

128 Atomoxetine, Placebo, and Parent Training in Autism
T. Smith B. L. Handen M. G. Aman L. E. Arnold S. L. Hyman X. Pan K. A. Buchan-Page

Citalopram Treatment of Young Children with Autism Spectrum Disorder (ASD): Correlation with Maternal History of Depression (Withdrawn)
A. W. Zimmerman K. Singh S. L. Connors

Developing and Testing an Intervention to Reduce Challenging Behaviors within Community and School-Based Mental Health Services (Withdrawn)
L. I. Brookman-Frazee W. Ganger M. Dyson C. Chlebowski M. Baker-Ericzen N. Stadnick

131 Effect of Treatment with OMEGA-3 Polyunsaturated Fatty Acids on Behavioural Measures in Children and Adolescents with Autism Spectrum Disorders
C. Moreno R. Calvo Escalona S. Gutierrez M. Graell J. Romo M. L. Dorado M. Giraldez C. Llorente C. Arango M. Parellada

132 Effect of Two Doses of Basimglurant on Behavioral Symptoms in Adolescent and Adult Patients with Fragile X Syndrome; Results from Fragxis, a Double-Blind, Placebo Controlled Study
J. Quiroz E. Wasef C. Y. Wong A. Kurian D. Deptula L. Banken M. Rabbia P. Fontoura L. Santarelli

133 Effectiveness of Over-the-counter Therapies for Autism
S. Bittker

134 From Experimental to Investigational: The Potential for Eye Tracking As a Biomarker for Outcome in Clinical Trials
F. Shic M. del Valle Rubido E. Hollander S. S. Jeste J. T. McCracken L. Scahill O. Khwaja L. Squassante S. Sadikhov J. Dukart E. S. Kim M. Perlmutter E. Sharer R. Paul R. J. Jou M. C. Lyons T. Apelian G. Berlin C. J. Ferretti A. Gavaletz R. L. Loomis J. N. Cowen T. Shimizu B. P. Taylor C. A. Wall R. Noone L. N. Antar L. Boak P. Fontoura D. Umbricht

135 Glutathione, Vitamin C and Cysteine Use in Children with Autism and Severe Behavior Concerns: A Double Blind, Placebo-Controlled Crossover Study
P. G. Williams

136 Irritability, Agitation and Agression in Persons with ASD: The ATN Pathway for Evaluation and Individualized Treatment Planning
A. Whitaker K. Morton R. A. Vasa A. Y. Hardan L. K. Fung A. A. Nozzolillo R. Mahajan P. Bernal J. Veenstra-Vander Weele D. L. Coury A. Silberman A. Wolfe

137 Maladaptive Behavior in Autism Spectrum Disorder: The Role of Emotion Experience and Emotion Regulation
A. Y. Hardan A. C. Samson J. J. Gross

138 Meta-Analysis of Pharmacotherapies for Treating Irritability, Agitation and Aggression in ASD
L. K. Fung R. Mahajan A. A. Nozzolillo P. Bernal A. Krasner B. Jo D. L. Coury A. Whitaker J. Veenstra-Vander Weele A. Y. Hardan

139 Nutritional and Dietary Interventions for Autism Spectrum Disorder – a Randomized, Controlled 12-Month Trial of a Combination of Six Treatments
J. Adams

140 Pharmacological Modulation of Excitatory/Inhibitory Balance in Autism Spectrum Disorder
L. A. Ajram J. Horder M. A. Mendez A. Galanopoulos L. Brennan R. Wichers D. J. Lythgoe S. C. Williams D. G. Murphy G. M. McAlonan

141 Physician Practices in Management of Second Generation Antipsychotic (SGA) Medications and Their Side Effects in Children and Adolescents with Autism Spectrum Disorders
D. L. Coury E. S. Matheson R. Baum P. Vora

142 Preliminary Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder
E. V. Pedapati L. K. Wink C. Erickson R. Gabriels C. A. Beresford D. Kaplan E. M. Morrow M. Siegel

143 Repetitive Transcranial Magnetic Stimulation over the Dorsolateral Prefrontal Cortex and Posterior Superior Temporal Sulcus Improves Core Symptoms of Autism
H. C. Ni J. Hung Y. Z. Huang

144 Results from a Phase I Proof-of-Mechanism Study with a Vasopressin 1a Receptor Antagonist in ASD
D. Umbricht M. del Valle Rubido F. Shic J. T. McCracken L. Scahill O. Khwaja L. Squassante L. Boak F. Bolognani P. Fontoura C. A. Wall R. J. Jou R. L. Loomis M. C. Lyons A. Gavaletz J. N. Cowen T. Apelian S. S. Jeste C. J. Ferretti B. P. Taylor G. Berlin R. Noone L. N. Antar E. Hollander

145 Safety and Exploratory Efficacy of Basimglurant in Pediatric Patients with Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
J. Quiroz C. Y. Wong E. Wasef D. Deptula L. Banken M. Rabbia P. Fontoura L. Santarelli

146 Study of Beliefs of Parents of Children with Autism Regarding Traditional Medicine in 4 Middle-East Countries
M. Habash M. Ftaiha

147 The Treatment of Refreactory Agression and Self Abusive Behaviors with Proporanolol
E. B. London

148 Trichuris Suis Ova (TSO) As an Immune-Inflammatory Treatment for Repetitive Behaviors in ASD
E. Hollander C. J. Ferretti B. P. Taylor R. Noone E. Racine E. Doernberg

149 Uptake 2 Transporter Blockade Can Ameliorate Sociability Deficits
G. G. Gould C. M. Smolik W. Koek M. A. Javors L. C. Daws